期刊文献+

蛋白酶体亚基RC2在失神经骨骼肌中的变化规律及其意义 被引量:4

Expression pattern and significance of proteasome subunit RC2 in rat denervated skeletal muscles
原文传递
导出
摘要 目的研究蛋白酶体亚基RC2在失神经骨骼肌中的变化规律及其意义。方法将48只SD大鼠,建立右下肢腓肠肌失神经支配模型,随机分为8组,每组6只,术后0 d为对照组,术后1、2、3、4、5、6、14 d为实验组;分别采用实时定量PCR和Western blot检测RC2在转录和蛋白水平的变化规律。结果RC2的mRNA从失神经后第1天开始表达上调,3 d达到高峰,为对照组的4.98倍,随后逐渐下降,14 d时降为对照组的0.42倍;各实验组与对照组相比,差异有统计学意义(P<0.05)。RC2在蛋白水平的变化与转录水平有着相同的趋势,但是变化幅度较转录水平为低。失神经后3 d达到高峰,为对照组的2.70倍,随后缓慢下降,14 d时降为正常侧的O.35倍;失神经术后1、6 d与对照组相比,差异无统计学意义(P>0.05)。2~5、14 d与对照组相比,差异有统计学意义(P<0.05)。结论蛋白酶体亚基RC2在失神经骨骼肌早期表达增强,提示泛素-蛋白酶体途径在失神经骨骼肌早期的蛋白快速降解中占有重要地位。 Objective To observe expression of proteasome subunit RC2 in denervated skeletal muscles, and investigate the molecular mechanism of skeletal muscle wasting. Methods A model of gastrocnemius muscle denervation at the right lower limb was established in 48 rats. They were divided into 8 groups with 6 each. The subsequent changes in RC2 mRNA and protein levels were determined by real- time quantitative PCR and Western blot, respectively. Results Expression of proteasome subunit RC2 mRNA in rat denervated gastrocnemius muscle was upregulated gradually, peaked in 3 days, then decreased (4.98 folds and 0.42 fold at day 3 and day 14, respectively; P 〈 0.05). The changes of protein levels were similar to that of mRNA levels, but the amplitude of changes was lower (2.70 folds and 0.35 fold at day 3 and day 14, respectively; P 〈 0.05). Conclusion After denervation, expression of proteasome subunit RC2 in skeletal muscle was upregulated. This supports the concept that denervationinduced muscle atrophy is, at least in part, regulated by the ubiquitin-proteasome proteolytie pathway.
出处 《中华手外科杂志》 CSCD 北大核心 2006年第2期124-126,共3页 Chinese Journal of Hand Surgery
基金 国家自然科学基金(30371463)
关键词 肌萎缩 骨骼 蛋白酶体 去神经支配 Muscle atrophy Muscle, skeletal Proteasome Denervation
  • 相关文献

参考文献10

  • 1Jagoe RT, Goldborg AL. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curt Opin Clin Nutr Metab Care,2001,4:183-190.
  • 2Reid MB. Response of the ubiquitin-proteasome pathway to changes in muscle activity. Am J Physiol Regul Integr Comp Physiol, 2005, 288 :R1423-1431.
  • 3Lecker SH, Solomon V, Mitch WE, et al. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr, 1999,129:227S-237S.
  • 4Hasselgren PO, Fischer JE. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann Surg, 1997,225:307-316.
  • 5Kania MA, Demartino GN, Baumeister W, et al. The proteasome subunit, C2, contains an important site for binding of the PA28 (11S)activator. Eur J Biochem, 1996,236:510-516.
  • 6Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^△△ct method. Methods, 2001,25:402-408.
  • 7Medina R, Wing SS, Goldberg AL, et al. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J, 1995,307 : 631-637.
  • 8Caplen NJ. RNAi as a gene therapy approach. Expert Opin Biol Ther,2003,3 : 575-586.
  • 9Tisdale MJ. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol,2005,3:209-217.
  • 10Tawa NE Jr, Odessey R, Goldberg AL. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest, 1997,100 : 197-203.

同被引文献64

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部